ID   BFVSBi007-A
AC   CVCL_F0RM
DR   BioSamples; SAMEA117512090
DR   hPSCreg; BFVSBi007-A
RX   PubMed=40795579;
CC   From: Baszucki Family Vascular Surgery Biobank, Stanford University School of Medicine; Stanford; USA.
CC   Donor information: Established from a melanoma patient treated with an immune checkpoint inhibitor (ICI). The treatment resulted in a potentially life-threatening syndrome involving myasthenia gravis, myositis, and myocarditis.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C60989; Myasthenia gravis
DI   NCIt; C34831; Myocarditis
DI   NCIt; C27578; Myositis
DI   ORDO; Orphanet_589; Myasthenia gravis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   73Y
CA   Induced pluripotent stem cell
DT   Created: 27-11-25; Last updated: 27-11-25; Version: 1
//
RX   PubMed=40795579; DOI=10.1016/j.scr.2025.103797;
RA   Huynh, Diem Thi Ngoc
RA   Noishiki, Chikage Anna
RA   Lai, Jacquelyn
RA   Yarahmadi, Pourya
RA   Le, Thao
RA   Tripathi, Dipti
RA   Ross Tacco, Ines
RA   Manhas, Amit
RA   Sallam, Karim
RA   Chen, Ian Y.
RA   Sayed, Nazish
RA   Nguyen, Patricia K.
RT   "Generation of an induced pluripotent stem cell line from a malignant
RT   melanoma patient who developed the immune checkpoint
RT   inhibitor-related myasthenia gravis, myositis, and myocarditis
RT   overlap syndrome.";
RL   Stem Cell Res. 87:103797-103797(2025).
//